WELCOME TO The PHARMACEUTICAL REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Uk Market News | December 16, 2016
On Thursday Morgan Stanley downgraded its target price on Valeant Pharmaceuticals (NYSE:VRX) shares issuing the company with a ‘Equal-Weight’ rating....
Pharmaceuticals | January 04, 2017
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that the Board of Directors has elected Richard (Dick) U. DeSchutter to serve as a director, effective January 2, 2017. With the addition of Mr. DeSchutter, Valeant has increased the size of its Board to 13 members, 12 of whom are independent....
Learn Bonds | January 16, 2017
Forging into 2017, analysts continue to cite Valeant Pharmaceutical Intl. Inc.’s (NYSE:VRX) debt, public image and reduced influence among its biggest challenges. The drug maker is now set on regaining portions of the confidence it lost during the last two years. Valeant shares rose to great peaks back in July 2015. A number of setbacks have since gradually chipped away at its all-time highs, and persist to the current day....
Smarter analyst | February 27, 2017
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced that it has rapidly scaled up its sales force by nearly 40 percent, effective immediately. “This is a demonstration of our commitment to GI and its relative importance to the broader value of our company,” said Joseph C. Papa, Chairman and CEO of Valeant. “The significant investments in Salix’s dedicated Primary Care Physician (PCP) sales force will help us further reach patients in need of irritable bowel syndrome with diarrhea (IBS-D) trea...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE